UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 8-K 

 

CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 22, 2020

 

Milestone Scientific Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction
of incorporation)

001-14053
(Commission
File Number)

13-3545623
(IRS Employer
Identification No.)

 

 

425 Eagle Rock Avenue, Suite 403

Roseland, NJ
(Address of principal executive offices)

07068
(Zip Code)

 

Registrant’s telephone number, including area code (973) 535-2717

 

(Former name or former address, if changed since last report.)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name on exchange on which registered

Common Stock

MLSS

NYSE American

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 


 

 

 

Item 8.01     Other Events

 

On May 22, 2020, Milestone Scientific Inc. (the “Company”) issued a press release announcing that the Company regained compliance with the stockholder’s equity requirements under the continued listing standards of the NYSE American LLC. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

Item 9.01     Financial Statements and Exhibits

 

 

(d)

Exhibits

 

The following exhibit is filed with this report:

 

 

99.1

Press release dated May 22, 2020 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Milestone Scientific Inc.
 

 

Dated: May 22, 2020 

By:  

/s/ Joseph D'Agostino

 

 

 

Joseph D’Agostino 

 

 

 

Chief Financial Officer

 

 

 

 
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Milestone Scientific Charts.
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Milestone Scientific Charts.